CME Sues CFTC Over Kalshi Perpetual Futures Approval
CME Group has sued the CFTC over its approval of Kalshi's perpetual futures contracts, challenging the regulatory process and raising questions about the future of crypto derivatives oversight.

CME Group has filed a lawsuit against the Commodity Futures Trading Commission, alleging the agency improperly approved Kalshi's application to list perpetual futures contracts. The suit, announced on Thursday, seeks to vacate the approval and the self-certified products, arguing the CFTC did not follow proper procedure. This legal challenge comes a day after outgoing CME CEO Terry Duffy signaled the exchange would take action over the approval.
The lawsuit centers on the CFTC's handling of Kalshi's perpetual futures, a type of derivative that allows traders to speculate on asset prices without an expiration date. For crypto traders, this case could have significant implications for how perpetual swaps are regulated in the US. If the court sides with CME, it may tighten the path for crypto derivatives products, potentially affecting liquidity and trading volumes on platforms like Kalshi. Traders can monitor the impact on related crypto assets through NowPrice's live crypto dashboard.
Market participants will be watching the court's decision closely, as it could set a precedent for how the CFTC evaluates future crypto derivative applications. The outcome may also influence other exchanges seeking to list similar products. Key dates to watch include the CFTC's response and any preliminary rulings, which could signal the direction of regulatory policy under the current administration.